Half-time photodynamic therapy in treatment of chronic central serous chorioretinopathy.
Vladimir SheptulinKonstantine PurtskhvanidzeJohann RoiderPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2018)
Half-time PDT has proven to be an effective and safe treatment option for patients with chronic CSC with a significant BCVA improvement during the follow-up after the therapy.